Dr. Renier J. Brentjens, MD, PhD, is a pioneering medical oncologist and global leader in cellular immunotherapy, specializing in the development of chimeric antigen receptor (CAR) T-cell therapies. He serves as Deputy Director and Chair of the Department of Medicine at Roswell Park Comprehensive Cancer Center, where he also holds the Katherine Anne Gioia Endowed Chair in Cancer Medicine. Dr. Brentjens earned his MD and PhD in Microbiology and Immunology from SUNY Buffalo, completed his residency in Internal Medicine at Yale-New Haven Hospital, and pursued fellowship training in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center. He is board-certified in Internal Medicine, Hematology, and Medical Oncology and is widely recognized for his leadership in advancing CAR T-cell therapy from bench to bedside.
Why they are a top doctor
Research papers · PubMed
159
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Cited by other doctors
36.5k
How often other doctors and researchers build on their work.
Background
Education
Medical school: State University of New York
Residency: Internal Medicine, Yale New Haven Hospital
Fellowship: Hematology Oncology, Memorial Sloan Kettering Cancer Center
Board certification: American Board of Internal Medicine, American Board of Medical Oncology
Awards
Warren Alpert Foundation Prize – 2024
Memberships and affiliations
American Society of Clinical Investigation
American Society of Hematology
AACR; Member – Society for Immunotherapy of Cancer